Cochlear Stock

Cochlear EBIT

The EBIT of Cochlear (COH.AX) as of Jun 21, 2026 is 522.9 T AUD.In the previous year, EBIT was 509.6 T AUD — a change of 2.61% (higher).

EBIT

522.9 TAUD

YoY

2.61%

Last updated:

In 2026, Cochlear's EBIT was 522.9 T AUD, a 2.61% increase from the 509.6 T AUD EBIT recorded in the previous year.

The Cochlear EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M AUD)
Date
EBIT (M AUD)
Jan 1, 2006
108.5 base
Jan 1, 2007
153.6 base
Jan 1, 2008
165 base
Jan 1, 2009
177.1 base
Jan 1, 2010
225.5 base
Jan 1, 2011
246.9 base
Jan 1, 2012
220.5 base
Jan 1, 2013
182.9 base
Jan 1, 2014
154.3 base
Jan 1, 2015
215.36 base
Jan 1, 2016
270.2 base
Jan 1, 2017
324.12 base
Jan 1, 2018
348 base
Jan 1, 2019
359.5 base
Jan 1, 2020
241 base
YEAREBIT (M AUD)
2031 est -
2030 est 871.34
2029 est 802.58
2028 est 695.26
2027 est 612.1
2026 est 536.73
2025 522.9
2024 509.6
2023 406.3
2022 394
2021 355.9
2020 241
2019 359.5
2018 348
2017 324.12
2016 270.2
2015 215.36
2014 154.3
2013 182.9
2012 220.5
2011 246.9
2010 225.5
2009 177.1
2008 165
2007 153.6
2006 108.5
Access this data via the Eulerpool API

Cochlear Revenue

Cochlear Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2006
452.3 M AUD
108.5 M AUD
80 M AUD
Jan 1, 2007
559.4 M AUD
153.6 M AUD
100.1 M AUD
Jan 1, 2008
601.7 M AUD
165 M AUD
115.2 M AUD
Jan 1, 2009
694.7 M AUD
177.1 M AUD
130.5 M AUD
Jan 1, 2010
734.8 M AUD
225.5 M AUD
155.2 M AUD
Jan 1, 2011
809.6 M AUD
246.9 M AUD
180.1 M AUD
Jan 1, 2012
779 M AUD
220.5 M AUD
56.8 M AUD
Jan 1, 2013
752.7 M AUD
182.9 M AUD
132.6 M AUD
Jan 1, 2014
804.9 M AUD
154.3 M AUD
93.7 M AUD
Jan 1, 2015
925.63 M AUD
215.36 M AUD
145.84 M AUD
Jan 1, 2016
1.13 B AUD
270.2 M AUD
188.92 M AUD
Jan 1, 2017
1.25 B AUD
324.12 M AUD
223.62 M AUD
Jan 1, 2018
1.36 B AUD
348 M AUD
245.8 M AUD
Jan 1, 2019
1.43 B AUD
359.5 M AUD
276.7 M AUD
Jan 1, 2020
1.32 B AUD
241 M AUD
-238.3 M AUD

Cochlear Margins

Cochlear stock margins

The Cochlear margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Cochlear. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Cochlear.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2006
71.04 %
23.99 %
17.69 %
Jan 1, 2007
71.17 %
27.46 %
17.89 %
Jan 1, 2008
72.31 %
27.42 %
19.15 %
Jan 1, 2009
72.12 %
25.49 %
18.79 %
Jan 1, 2010
73.31 %
30.69 %
21.12 %
Jan 1, 2011
72.62 %
30.5 %
22.25 %
Jan 1, 2012
74.53 %
28.31 %
7.29 %
Jan 1, 2013
72.55 %
24.3 %
17.62 %
Jan 1, 2014
69.35 %
19.17 %
11.64 %
Jan 1, 2015
71.35 %
23.27 %
15.76 %
Jan 1, 2016
71.93 %
23.9 %
16.71 %
Jan 1, 2017
71.94 %
25.85 %
17.83 %
Jan 1, 2018
73.72 %
25.52 %
18.02 %
Jan 1, 2019
75.85 %
25.2 %
19.39 %
Jan 1, 2020
74.54 %
18.25 %
-18.04 %

Cochlear Stock analysis

What does Cochlear do? Cochlear Ltd is an Australian-based medical technology company founded in 1981 by engineer Professor Graeme Clark. The company specializes in Cochlear implant systems and other hearing devices. Cochlear Ltd offers accessories, services, and rehabilitation training for individuals with hearing impairments. The company's products are available for both children and adults with varying degrees of hearing loss. Cochlear Ltd operates in different sectors, including Cochlear implant systems, hearing aids, and wireless accessories and streaming systems under the brand names Nucleus® and Baha®. Nucleus® systems utilize a fully implantable cochlear implant and external speech processor to convert sound into electrical signals for interpretation by the brain. Baha® systems are bone-anchored hearing devices for individuals with unilateral to moderate hearing impairments. Cochlear Ltd also provides wireless accessories and streaming systems to connect devices like mobile phones, TVs, and music players to the hearing aids and cochlear implants, improving hearing performance and enhancing social lives. The company has a strong global presence, operating in over 100 countries with headquarters in Australia, multiple production facilities, and research centers. Cochlear Ltd has received numerous awards and recognition for its products and services and is committed to researching and developing new therapies and technologies to improve the lives of individuals with hearing impairments. Cochlear is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Cochlear's EBIT

Cochlear's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Cochlear's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Cochlear's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Cochlear’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Cochlear stock

EBIT of Cochlear amounted to 509.6 T AUD 522.9 T

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Cochlear

All Key Metrics — Cochlear